QTRX
Quanterix Corporation
Price Chart
Latest Quote
$3.39
+0.51 (+17.71%)
Current Price
| Previous Close | $2.88 |
| Open | $2.95 |
| Day High | $3.43 |
| Day Low | $2.95 |
| Volume | 3,071,346 |
Stock Information
| Shares Outstanding | 47.11M |
| Total Debt | $35.34M |
| Cash Equivalents | $99.27M |
| Revenue | $144.98M |
| Net Income | $-104.19M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $159.69M |
| EPS (TTM) | $-2.35 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $95.76M |
| Sales | $144.98M |
| Income | $-104.19M |
| Book/sh | $6.00 |
| Cash/sh | $2.11 |
| Employees | 450 |
Financial Ratios
| Quick Ratio | 2.54 |
| Current Ratio | 3.72 |
| Debt/Eq | 12.52 |
Returns & Margins
| ROA | -13.39% |
| ROE | -34.81% |
| Gross Margin | 45.31% |
| Operating Margin | -59.12% |
| Profit Margin | -71.86% |
Ownership
| Insider Ownership | 6.29% |
| Institutional Ownership | 85.44% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -2.49 |
| P/S | 1.10 |
| P/B | 0.57 |
Analyst Data
| Recommendation | hold |
| Target Price | $4.33 |
Technical Indicators
| SMA20 | $3.11 |
| SMA50 | $3.11 |
| SMA200 | $5.14 |
| RSI | 57.14 |
| ATR | 0.3543 |
| Shares Float | 38.49M |
| Short Float | 12.09% |
| Short Ratio | 3.34 |
| Volatility | 1.12 |
| Rel Volume | 2.63 |
Performance History
| Week | +11.88% |
| Month | +35.06% |
| Quarter | -23.13% |
| 6 Months | -53.94% |
| YTD | -47.28% |
| Year | -44.79% |
| 3 Years | -85.26% |
| 5 Years | -94.90% |
| 10 Years | -80.60% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $3.39 | 3,071,100 |
| 2026-06-17 | $2.88 | 1,412,400 |
| 2026-06-16 | $3.06 | 929,000 |
| 2026-06-15 | $3.10 | 1,050,000 |
| 2026-06-12 | $3.10 | 706,300 |
| 2026-06-11 | $3.03 | 627,900 |
| 2026-06-10 | $3.07 | 703,300 |
| 2026-06-09 | $3.09 | 820,000 |
| 2026-06-08 | $3.13 | 601,500 |
| 2026-06-05 | $3.30 | 928,000 |
| 2026-06-04 | $3.80 | 662,300 |
| 2026-06-03 | $3.53 | 701,400 |
| 2026-06-02 | $3.50 | 1,208,600 |
| 2026-06-01 | $3.50 | 2,037,800 |
| 2026-05-29 | $3.06 | 811,500 |
| 2026-05-28 | $3.05 | 2,908,800 |
| 2026-05-27 | $2.65 | 821,400 |
| 2026-05-26 | $2.68 | 798,100 |
| 2026-05-22 | $2.69 | 815,000 |
| 2026-05-21 | $2.64 | 1,720,900 |
| 2026-05-20 | $2.52 | 1,107,300 |
| 2026-05-19 | $2.51 | 974,000 |
About Quanterix Corporation
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, the company offers contract research and clinical laboratory testing services, including research and clinical trial testing, and lucent diagnostic services. The company primarily operates in the areas of neurology, oncology and immunology, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and sales force and distributors. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
đ° Latest News
Quanterix (QTRX) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-07T14:44:10Z
Quanterix Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-07T04:08:48Z
Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates
Zacks âĸ 2026-05-06T21:25:07Z
How The Quanterix (QTRX) Story Is Shifting After The Latest Fair Value Reset
Simply Wall St. âĸ 2026-05-03T02:14:43Z
Quanterix (QTRX) Q4 2025 Earnings Call Transcript
Motley Fool âĸ 2026-03-03T17:50:52Z
Quanterix Corporation Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-03T13:30:00Z
Quanterix Corp (QTRX) Q4 2025 Earnings Call Highlights: Revenue Surge Amidst Strategic Shifts
GuruFocus.com âĸ 2026-03-03T05:01:30ZQuanterix Q4 Earnings Call Highlights
MarketBeat âĸ 2026-03-02T22:32:37Z
Quanterix Corporation (QTRX) Reports Q4 Loss, Beats Revenue Estimates
Zacks âĸ 2026-03-02T22:10:02Z
With 68% ownership, Quanterix Corporation (NASDAQ:QTRX) boasts of strong institutional backing
Simply Wall St. âĸ 2026-02-14T13:03:31Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $73,938,000 | $54,317,000 | $48,144,000 | $60,159,000 |
| Cost Of Revenue | $73,938,000 | $54,317,000 | $48,144,000 | $60,159,000 |
| Total Revenue | $138,654,000 | $135,436,000 | $121,139,000 | $104,952,000 |
| Operating Revenue | $138,654,000 | $135,436,000 | $121,139,000 | $104,952,000 |
| Expenses | ||||
| Total Expenses | $248,469,000 | $188,052,000 | $165,802,000 | $179,660,000 |
| Rent Expense Supplemental | $844,000 | $3,020,000 | $3,712,000 | $1,411,000 |
| Other Income Expense | $-11,023,000 | $-136,000 | $1,189,000 | $-29,833,000 |
| Other Non Operating Income Expenses | $157,000 | $-136,000 | $2,517,000 | $-277,000 |
| Net Non Operating Interest Income Expense | $8,567,000 | $14,655,000 | $15,839,000 | $5,131,000 |
| Operating Expense | $174,531,000 | $133,735,000 | $117,658,000 | $119,501,000 |
| Other Operating Expenses | $-243,000 | $-1,985,000 | $-1,229,000 | $-570,000 |
| General And Administrative Expense | $138,852,000 | $104,638,000 | $92,823,000 | $93,262,000 |
| Total Other Finance Cost | - | - | $-15,839,000 | $-5,131,000 |
| Selling And Marketing Expense | - | - | - | $91,995,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-107,150,000 | $-38,531,000 | $-28,354,000 | $-99,574,000 |
| Net Interest Income | $8,567,000 | $14,655,000 | $15,839,000 | $5,131,000 |
| Interest Income | $8,567,000 | $14,655,000 | $15,839,000 | $5,131,000 |
| Normalized Income | $-96,484,280 | $-38,531,000 | $-27,304,880 | $-76,224,760 |
| Net Income From Continuing And Discontinued Operation | $-107,150,000 | $-38,531,000 | $-28,354,000 | $-99,574,000 |
| Total Operating Income As Reported | $-125,542,000 | $-52,616,000 | $-45,991,000 | $-104,264,000 |
| Net Income Common Stockholders | $-107,150,000 | $-38,531,000 | $-28,354,000 | $-99,574,000 |
| Net Income | $-107,150,000 | $-38,531,000 | $-28,354,000 | $-99,574,000 |
| Net Income Including Noncontrolling Interests | $-107,150,000 | $-38,531,000 | $-28,354,000 | $-99,574,000 |
| Net Income Continuous Operations | $-107,150,000 | $-38,531,000 | $-28,354,000 | $-99,574,000 |
| Pretax Income | $-112,271,000 | $-38,097,000 | $-27,635,000 | $-99,410,000 |
| Special Income Charges | $-11,180,000 | $0 | $-1,328,000 | $-29,556,000 |
| Interest Income Non Operating | $8,567,000 | $14,655,000 | $15,839,000 | $5,131,000 |
| Operating Income | $-109,815,000 | $-52,616,000 | $-44,663,000 | $-74,708,000 |
| Gross Profit | $64,716,000 | $81,119,000 | $72,995,000 | $44,793,000 |
| Per Share | ||||
| Diluted EPS | $-2.51 | $-1.00 | $-0.75 | $-2.61 |
| Basic EPS | $-2.51 | $-1.00 | $-0.75 | $-2.61 |
| Other | ||||
| Tax Effect Of Unusual Items | $-514,280 | $0 | $-278,880 | $-6,206,760 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-79,710,000 | $-44,260,000 | $-35,045,000 | $-39,028,000 |
| Total Unusual Items | $-11,180,000 | $0 | $-1,328,000 | $-29,556,000 |
| Total Unusual Items Excluding Goodwill | $-11,180,000 | $0 | $-1,328,000 | $-29,556,000 |
| Reconciled Depreciation | $18,925,000 | $8,356,000 | $8,290,000 | $6,124,000 |
| EBITDA (Bullshit earnings) | $-90,890,000 | $-44,260,000 | $-36,373,000 | $-68,584,000 |
| EBIT | $-109,815,000 | $-52,616,000 | $-44,663,000 | $-74,708,000 |
| Diluted Average Shares | $42,639,000 | $38,367,000 | $37,594,000 | $36,990,965 |
| Basic Average Shares | $42,639,000 | $38,367,000 | $37,594,000 | $36,990,965 |
| Diluted NI Availto Com Stockholders | $-107,150,000 | $-38,531,000 | $-28,354,000 | $-99,574,000 |
| Tax Provision | $-5,121,000 | $434,000 | $719,000 | $164,000 |
| Impairment Of Capital Assets | $15,727,000 | $0 | $1,328,000 | $29,556,000 |
| Restructuring And Mergern Acquisition | $-4,547,000 | $0 | $0 | $3,755,000 |
| Research And Development | $35,922,000 | $31,082,000 | $26,064,000 | $26,809,000 |
| Selling General And Administration | $138,852,000 | $104,638,000 | $92,823,000 | $93,262,000 |
| Other Gand A | $138,008,000 | $101,618,000 | $89,111,000 | $91,851,000 |
| Rent And Landing Fees | $844,000 | $3,020,000 | $3,712,000 | $1,411,000 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $137,567,000 | $326,007,000 | $343,924,000 | $350,416,000 |
| Total Assets | $418,766,000 | $406,533,000 | $428,567,000 | $433,582,000 |
| Total Non Current Assets | $206,509,000 | $42,939,000 | $46,472,000 | $52,058,000 |
| Other Non Current Assets | $8,010,000 | $5,419,000 | $4,261,000 | $3,508,000 |
| Goodwill And Other Intangible Assets | $158,163,000 | $4,031,000 | $6,034,000 | $7,516,000 |
| Other Intangible Assets | $131,787,000 | $4,031,000 | $6,034,000 | $7,516,000 |
| Current Assets | $212,257,000 | $363,594,000 | $382,095,000 | $381,524,000 |
| Other Current Assets | $9,290,000 | $9,556,000 | $9,234,000 | $6,803,000 |
| Inventory | $54,763,000 | $32,775,000 | $26,123,000 | $16,964,000 |
| Receivables | $29,972,000 | $32,141,000 | $25,414,000 | $19,017,000 |
| Accounts Receivable | $29,972,000 | $32,141,000 | $25,414,000 | $19,017,000 |
| Allowance For Doubtful Accounts Receivable | $-2,368,000 | $-1,042,000 | $-454,000 | $-118,000 |
| Gross Accounts Receivable | $32,340,000 | $33,183,000 | $25,868,000 | $19,135,000 |
| Cash Cash Equivalents And Short Term Investments | $118,232,000 | $289,122,000 | $321,324,000 | $338,740,000 |
| Cash And Cash Equivalents | $29,839,000 | $56,709,000 | $174,422,000 | $338,740,000 |
| Cash Equivalents | $17,219,000 | $44,426,000 | $162,260,000 | $306,097,000 |
| Cash Financial | $12,620,000 | $12,283,000 | $12,162,000 | $32,643,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $37,239,000 | $37,371,000 | $41,464,000 | $44,104,000 |
| Long Term Debt And Capital Lease Obligation | $29,323,000 | $32,615,000 | $37,223,000 | $41,417,000 |
| Current Debt And Capital Lease Obligation | $7,916,000 | $4,756,000 | $4,241,000 | $2,687,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $123,036,000 | $76,495,000 | $78,609,000 | $75,650,000 |
| Total Non Current Liabilities Net Minority Interest | $48,274,000 | $34,488,000 | $39,627,000 | $44,301,000 |
| Other Non Current Liabilities | $5,024,000 | - | - | - |
| Non Current Deferred Liabilities | $13,927,000 | $1,873,000 | $2,404,000 | $2,884,000 |
| Non Current Deferred Taxes Liabilities | $8,097,000 | $800,000 | $1,177,000 | $1,469,000 |
| Current Liabilities | $74,762,000 | $42,007,000 | $38,982,000 | $31,349,000 |
| Other Current Liabilities | $6,869,000 | - | - | $386,000 |
| Current Deferred Liabilities | $20,728,000 | $8,827,000 | $9,468,000 | $8,644,000 |
| Payables And Accrued Expenses | $24,270,000 | $15,804,000 | $11,103,000 | $8,983,000 |
| Payables | $14,693,000 | $7,971,000 | $5,870,000 | $4,022,000 |
| Total Tax Payable | $1,125,000 | $1,018,000 | $822,000 | $186,000 |
| Accounts Payable | $13,568,000 | $6,953,000 | $5,048,000 | $3,836,000 |
| Equity | ||||
| Common Stock Equity | $295,730,000 | $330,038,000 | $349,958,000 | $357,932,000 |
| Total Equity Gross Minority Interest | $295,730,000 | $330,038,000 | $349,958,000 | $357,932,000 |
| Stockholders Equity | $295,730,000 | $330,038,000 | $349,958,000 | $357,932,000 |
| Gains Losses Not Affecting Retained Earnings | $-723,000 | $-3,080,000 | $-1,672,000 | $-2,538,000 |
| Other Equity Adjustments | $-723,000 | $-3,080,000 | $-1,672,000 | $-2,538,000 |
| Retained Earnings | $-577,231,000 | $-470,081,000 | $-431,550,000 | $-403,196,000 |
| Other | ||||
| Ordinary Shares Number | $46,744,000 | $38,544,000 | $38,014,000 | $37,279,994 |
| Share Issued | $46,744,000 | $38,544,000 | $38,014,000 | $37,279,994 |
| Tangible Book Value | $137,567,000 | $326,007,000 | $343,924,000 | $350,416,000 |
| Invested Capital | $295,730,000 | $330,038,000 | $349,958,000 | $357,932,000 |
| Working Capital | $137,495,000 | $321,587,000 | $343,113,000 | $350,175,000 |
| Capital Lease Obligations | $37,239,000 | $37,371,000 | $41,464,000 | $44,104,000 |
| Total Capitalization | $295,730,000 | $330,038,000 | $349,958,000 | $357,932,000 |
| Additional Paid In Capital | $873,637,000 | $803,160,000 | $783,142,000 | $763,629,000 |
| Capital Stock | $47,000 | $39,000 | $38,000 | $37,000 |
| Common Stock | $47,000 | $39,000 | $38,000 | $37,000 |
| Non Current Deferred Revenue | $5,830,000 | $1,073,000 | $1,227,000 | $1,415,000 |
| Long Term Capital Lease Obligation | $29,323,000 | $32,615,000 | $37,223,000 | $41,417,000 |
| Current Deferred Revenue | $20,728,000 | $8,827,000 | $9,468,000 | $8,644,000 |
| Current Capital Lease Obligation | $7,916,000 | $4,756,000 | $4,241,000 | $2,687,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $14,979,000 | $12,620,000 | $14,170,000 | $11,035,000 |
| Current Accrued Expenses | $9,577,000 | $7,833,000 | $5,233,000 | $4,961,000 |
| Goodwill | $26,376,000 | $0 | - | $0 |
| Net PPE | $40,336,000 | $33,489,000 | $36,177,000 | $41,034,000 |
| Accumulated Depreciation | $-25,827,000 | $-18,824,000 | $-14,121,000 | $-11,009,000 |
| Gross PPE | $66,163,000 | $52,313,000 | $50,298,000 | $52,043,000 |
| Leases | $16,132,000 | $13,291,000 | $13,074,000 | $13,688,000 |
| Other Properties | $39,525,000 | $30,987,000 | $31,392,000 | $32,976,000 |
| Machinery Furniture Equipment | $10,506,000 | $8,035,000 | $5,832,000 | $5,379,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $30,006,000 | $17,580,000 | $15,570,000 | $8,040,000 |
| Work In Process | $11,030,000 | $7,980,000 | $5,439,000 | $3,415,000 |
| Raw Materials | $13,727,000 | $7,215,000 | $5,114,000 | $5,509,000 |
| Other Short Term Investments | $88,393,000 | $232,413,000 | $146,902,000 | $0 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-79,848,000 | $-38,532,000 | $-22,690,000 | $-60,225,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-77,236,000 | $-35,164,000 | $-18,849,000 | $-48,611,000 |
| Cash Flow From Continuing Operating Activities | $-77,236,000 | $-35,164,000 | $-18,849,000 | $-48,611,000 |
| Operating Gains Losses | - | - | - | $-213,000 |
| Investing Activities | ||||
| Capital Expenditure | $-2,612,000 | $-3,368,000 | $-3,841,000 | $-11,614,000 |
| Investing Cash Flow | $50,231,000 | $-82,265,000 | $-148,454,000 | $-11,094,000 |
| Cash Flow From Continuing Investing Activities | $50,231,000 | $-82,265,000 | $-148,454,000 | $-11,094,000 |
| Net Other Investing Changes | - | - | - | $520,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-708,000 | $456,000 | $2,691,000 | $2,311,000 |
| Cash Flow From Continuing Financing Activities | $-708,000 | $456,000 | $2,691,000 | $2,311,000 |
| Net Other Financing Charges | $-1,446,000 | $-2,610,000 | $-198,000 | - |
| Issuance Of Capital Stock | - | - | $0 | $0 |
| Net Common Stock Issuance | - | - | $0 | $0 |
| Common Stock Issuance | - | - | $0 | $0 |
| Other | ||||
| End Cash Position | $33,180,000 | $59,319,000 | $177,026,000 | $341,337,000 |
| Beginning Cash Position | $59,319,000 | $177,026,000 | $341,337,000 | $399,269,000 |
| Effect Of Exchange Rate Changes | $1,574,000 | $-734,000 | $301,000 | $-538,000 |
| Changes In Cash | $-27,713,000 | $-116,973,000 | $-164,612,000 | $-57,394,000 |
| Proceeds From Stock Option Exercised | $738,000 | $3,066,000 | $2,889,000 | $2,311,000 |
| Net Investment Purchase And Sale | $146,072,000 | $-78,897,000 | $-144,613,000 | $0 |
| Sale Of Investment | $215,829,000 | $216,709,000 | $31,000,000 | $0 |
| Purchase Of Investment | $-69,757,000 | $-295,606,000 | $-175,613,000 | $0 |
| Net Business Purchase And Sale | $-93,229,000 | $0 | $0 | - |
| Purchase Of Business | $-93,229,000 | $0 | $0 | - |
| Net PPE Purchase And Sale | $-2,612,000 | $-3,368,000 | $-3,841,000 | $-11,614,000 |
| Purchase Of PPE | $-2,612,000 | $-3,368,000 | $-3,841,000 | $-11,614,000 |
| Change In Working Capital | $-6,898,000 | $-18,786,000 | $-15,191,000 | $4,296,000 |
| Change In Other Working Capital | $-16,871,000 | $-4,866,000 | $-2,063,000 | $2,599,000 |
| Change In Other Current Assets | $252,000 | $-1,215,000 | $-717,000 | $-822,000 |
| Change In Payables And Accrued Expense | $-8,442,000 | $2,121,000 | $5,599,000 | $-8,886,000 |
| Change In Accrued Expense | $-7,914,000 | $1,398,000 | $4,410,000 | $-3,599,000 |
| Change In Payable | $-528,000 | $723,000 | $1,189,000 | $-5,287,000 |
| Change In Account Payable | $-528,000 | $723,000 | $1,189,000 | $-5,287,000 |
| Change In Prepaid Assets | $3,521,000 | $-443,000 | $-2,371,000 | $-738,000 |
| Change In Inventory | $4,033,000 | $-6,679,000 | $-8,944,000 | $7,243,000 |
| Change In Receivables | $10,609,000 | $-7,704,000 | $-6,695,000 | $5,156,000 |
| Changes In Account Receivables | $10,609,000 | $-7,704,000 | $-6,695,000 | $5,156,000 |
| Other Non Cash Items | $-3,266,000 | $345,000 | $140,000 | $-641,000 |
| Stock Based Compensation | $20,718,000 | $19,987,000 | $16,823,000 | $15,383,000 |
| Asset Impairment Charge | $8,380,000 | $588,000 | $1,697,000 | $25,801,000 |
| Amortization Of Securities | $-2,078,000 | $-6,833,000 | $-1,964,000 | $0 |
| Deferred Tax | $-5,867,000 | $-290,000 | $-290,000 | $-226,000 |
| Deferred Income Tax | $-5,867,000 | $-290,000 | $-290,000 | $-226,000 |
| Depreciation Amortization Depletion | $18,925,000 | $8,356,000 | $8,290,000 | $6,124,000 |
| Depreciation And Amortization | $18,925,000 | $8,356,000 | $8,290,000 | $6,124,000 |
| Depreciation | $18,925,000 | $8,356,000 | $8,290,000 | $6,124,000 |
| Net Income From Continuing Operations | $-107,150,000 | $-38,531,000 | $-28,354,000 | $-99,574,000 |
| Income Tax Paid Supplemental Data | - | $875,000 | $808,000 | $684,000 |
| Change In Other Current Liabilities | - | $-4,072,000 | $-2,698,000 | $-256,000 |
| Repayment Of Debt | - | - | $0 | $0 |
| Interest Paid Supplemental Data | - | - | $0 | $0 |
| Net Issuance Payments Of Debt | - | - | $0 | $0 |
| Net Long Term Debt Issuance | - | - | $0 | $0 |
| Long Term Debt Payments | - | - | $0 | $0 |
| Net Foreign Currency Exchange Gain Loss | - | - | - | $-219,000 |
| Gain Loss On Sale Of PPE | - | - | - | $6,000 |
Fetched: 2026-06-17